Medicare Enrolled
Dr. Patrick Ward, MD
Hematology & Oncology · Cincinnati, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ward from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ward?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ward
Dr. Patrick Ward is a hematology & oncology specialist in Cincinnati, OH, with 21 years of NPI registration. Based on federal Medicare data, Dr. Ward performed 48,041 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ward received a total of $12,959 from 24 pharmaceutical and/or device companies across 50 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ward is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 12% volume in OH
$12,959 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗48,041
Medicare services
Top 12% in OH for hematology & oncology
Not available
Unique patients (not deduplicated)
$28
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 16,204 | $43 | $147 |
| Nivolumab injection (Opdivo) | 13,660 | $24 | $82 |
| Denosumab injection (Prolia/Xgeva) | 3,540 | $18 | $70 |
| Immune globulin infusion (Octagam) This procedure involves the administration of immune globulin medication directly into a vein. It is provided in a non-lyophilized liquid form. |
2,360 | $34 | $252 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,064 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,550 | $1 | $122 |
| Iron infusion (Monoferric) | 1,300 | $16 | $78 |
| Injection, leucovorin calcium, per 50 mg | 1,006 | $3 | $27 |
| Injection, granisetron hydrochloride, 100 mcg | 950 | $0 | $25 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
715 | $2 | $14 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
645 | $8 | $35 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
504 | $10 | $62 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
476 | $93 | $683 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $91 | $305 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
322 | $59 | $205 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
284 | $21 | $152 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
262 | $11 | $105 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
232 | $7 | $462 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
147 | $47 | $332 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
139 | $10 | $93 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
127 | $0 | $5 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
103 | $44 | $304 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
80 | $2 | $19 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
79 | $23 | $141 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
76 | $1 | $7 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
64 | $19 | $96 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
64 | $21 | $156 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
59 | $18 | $111 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
55 | $40 | $281 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
54 | $129 | $986 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
52 | $91 | $300 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
48 | $15 | $91 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
46 | $15 | $97 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
43 | $23 | $249 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
38 | $16 | $78 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
38 | $9 | $73 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
35 | $13 | $58 |
| Iron level test | 30 | $6 | $26 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
29 | $9 | $34 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
27 | $117 | $475 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
23 | $62 | $251 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $127 | $585 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $136 | $410 |
| PSA test (prostate cancer screening) | 19 | $18 | $91 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
10.2% high complexity
84.6% medium
5.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,959
Total received (2018-2024)
Avg $1,851/year across 7 years
Top 25% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
50
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$7,559
2023
$4,255
2022
$356
2021
$128
2020
$38
2019
$139
2018
$483
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$3,052
Daiichi Sankyo Inc.
$2,080
Eli Lilly and Company
$1,875
ABBVIE INC.
$253
Amgen Inc.
$131
Janssen Biotech, Inc.
$70
PFIZER INC.
$26
Gilead Sciences, Inc.
$24
Genentech USA, Inc.
$21
Regeneron Healthcare Solutions, Inc.
$15
Lilly USA, LLC
$11
Top 3 companies account for 92.7% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,177
Fresenius Kabi USA, LLC
$2,200
Daiichi Sankyo Inc.
$2,080
Amgen Inc.
$1,913
Eli Lilly and Company
$1,875
Janssen Biotech, Inc.
$520
ABBVIE INC.
$253
Genentech USA, Inc.
$137
Merck Sharp & Dohme Corporation
$136
EMD Serono, Inc.
$122
Clovis Oncology, Inc.
$112
Myovant Sciences Inc.
$95
Takeda Pharmaceuticals U.S.A., Inc.
$73
Genentech, Inc.
$50
Gilead Sciences, Inc.
$36
Lilly USA, LLC
$35
G1 Therapeutics, Inc.
$29
PFIZER INC.
$26
E.R. Squibb & Sons, L.L.C.
$22
Regeneron Healthcare Solutions, Inc.
$15
Novartis Pharmaceuticals Corporation
$14
Pharmacyclics LLC, An AbbVie Company
$14
Incyte Corporation
$14
Bayer HealthCare Pharmaceuticals Inc.
$13
Top 3 companies account for 57.5% of all-time payments
Associated products mentioned in payments ›
Alecensa · COSELA · EPKINLY · ERLEADA · IBRANCE · IMBRUVICA · IMFINZI · KEYTRUDA · KISQALI · LIBTAYO · LUMAKRAS · MONJUVI · NINLARO · OPDIVO · ORGOVYX · RETEVMO · RYBREVANT · Rubraca · Stimufend · TECENTRIQ · TEPMETKO · VERZENIO · Xofigo
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
74
County median income
$70,816
Nearest hospital to ZIP centroid (approximate)
BETHESDA NORTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ward is a mixed practice specialist, with above-average Medicare volume (top 12% in OH), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ward experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Ward performed 16,204 pembrolizumab injection (keytruda) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ward receive payments from pharmaceutical companies?
Yes. Dr. Ward received a total of $12,959 from 24 companies across 50 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ward's costs compare to other hematology & oncology specialists in Cincinnati?
Dr. Ward's average Medicare payment per service is $28. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ward) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Cincinnati
Browse hematology & oncology specialists in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in OH
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in OH
Which OH hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Fresenius Kabi USA, LLC Payments to Doctors
See all physicians who received payments from Fresenius Kabi USA, LLC.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology